Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study

Gouw, Sc; Van Der Bom, Jg; Auerswald, G; Escuriola Ettingshausen, C; Tedgard, U; Van Den Berg, Hm; Altisent, C; Chambost, H; Cid, Ar; Haya, S; Kreuz, W; Van Geet, C; Peerlinck, K; Liesner, R; Petrini, P; Rivard, G; Santagostino, E; Mancuso, M; Villar, A; Jimenez-Yuste, V; Yee, Tt; Lee, Ca